1. U-M CVC - NIH Post-doctoral Training Grant -- University Of Michigan Health System
CD39 ectonucleotidase in coagulation and inflammation. Genetic modifiers of obesity. Novel genetic modifiers of thrombosis. Genetic modifiers of hypertension. The purpose of this NIH sponsored training grant is to provide an intensive research...
http://www.med.umich.edu/cvc/prof/prtrain.htm

2. Hemophilia Clinical Trials: Department of Pediatrics: University of Iowa Health Care -- Ui Health...
Role of Genetic Modifiers in Bleeding Disorders (NIH Study) This study is open to enrollment for people with vWD, Gray Platelet Syndrome and platelet disorders. Department of Pediatrics: Subjects may be in the study for 75 exposures or 3 years.
http://www.uihealthcare.com/depts/med/pediatrics/trials/hemophilia.html

3. Antipsychotics Pose Risk of Fatal Cardiac Effects - February 15, 2003 - American Family Physician...
-- Adjusted for age, sex, state, heart failure, other heart disease, ever use of angiotensin-converting enzyme inhibitor, ever use of antianginal drug, ever use of calcium channel blocker, and ever use of coagulation modifier.
http://www.aafp.org/afp/20030215/tips/32.html